IP Library Granted Patent US 12,433,982
Granted Patent B2
US 12,433,982 · App. 17/981,635 · Granted Oct 7, 2025

Peritoneal dialysis cycler having disinfection

Inventor: Olof Jansson (Vellinge, SE)
Assignees: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
A61M1/282A61M1/1635A61M1/1639A61M1/1686A61M1/1688A61M1/285
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,433,982
App. No.
17/981,635
Granted
Oct 7, 2025
Kind
B2
Abstract

A peritoneal dialysis (“PD”) system includes a first volumetric balancing chamber including a first fixed volume chamber and a first diaphragm positioned and arranged to extend back and forth within the first fixed volume chamber, the first diaphragm separating a fresh PD fluid side from a used PD fluid side of the first volumetric balancing chamber; a second volumetric balancing chamber including a second fixed volume chamber and a second diaphragm positioned and arranged to extend back and forth within the second fixed volume chamber, the second diaphragm separating a fresh PD fluid side from a used PD fluid side of the second volumetric balancing chamber; and a PD fluid pump positioned and arranged to pump used PD fluid back and forth between the used PD fluid sides of the first and second volumetric balancing chamber.

Claims (16)

1. A peritoneal dialysis (“PD”) system comprising:

a first volumetric balancing chamber including a first fixed volume chamber and a first diaphragm positioned and arranged to extend back and forth within the first fixed volume chamber, the first diaphragm separating a fresh PD fluid side from a used PD fluid side of the first volumetric balancing chamber;

a second volumetric balancing chamber including a second fixed volume chamber and a second diaphragm positioned and arranged to extend back and forth within the second fixed volume chamber, the second diaphragm separating a fresh PD fluid side from a used PD fluid side of the second volumetric balancing chamber; and

a PD fluid pump positioned and arranged to pump used PD fluid back and forth between the used PD fluid sides of the first and second volumetric balancing chambers.

2. The PD system of claim 1 , which includes at least one valve in fluid communication with the fresh PD fluid side of one of the first or second volumetric balancing chambers, and wherein fresh PD fluid is discharged from the fresh PD fluid side through the at least one valve when the PD fluid pump pumps used PD fluid to the used PD fluid side of the first or second volumetric balancing chamber.

3. The PD system of claim 2 , which includes a control unit configured to operate the PD fluid pump, the control unit configured to determine an amount of fresh PD fluid discharged from the fresh PD fluid side of the first or second volumetric balancing chamber via (i) monitoring a pumping output of the PD fluid pump and/or (ii) using a known volume of the first or second fixed volume chamber.

4. The PD system of claim 1 , which includes at least one valve in fluid communication with the fresh PD fluid side of the first or second volumetric balancing chamber, and wherein fresh PD fluid is drawn into the fresh PD fluid side through the at least one valve when the PD fluid pump pumps used PD fluid from the used PD fluid side of the first or second volumetric balancing chamber.

5. The PD system of claim 1 , which is configured during a patient drain such that the PD fluid pump pumps used PD fluid through a patient line, through one of the first or second volumetric balancing chambers, and through a drain line.

6. The PD system of claim 5 , wherein the PD fluid pump pumps used PD fluid through a return lumen of the patient line, and wherein the patient line further includes an output lumen for delivering fresh PD fluid to a patient.

7. The PD system of claim 5 , which includes a control unit configured to operate the PD fluid pump during the patient drain, the control unit configured to determine an amount of used PD fluid removed during the patient drain via monitoring at least one pumping output of the PD fluid pump.

8. The PD system of claim 1 , which includes a first heater in fluid communication with the fresh PD fluid sides of the first and second volumetric balancing chambers, and a second heater in fluid communication with the used PD fluid sides of the first and second volumetric balancing chambers, wherein the first heater is used in a sterilization sequence and the second heater is used in a disinfection sequence.

9. The PD system of claim 8 , wherein the first heater is further used to heat fresh PD fluid for treatment.

10. The PD system of claim 8 , wherein the first heater heats fresh PD fluid to at least 120° C. for the sterilization sequence, and the second heater heats fresh or used PD fluid to at least 65° C. for the disinfection sequence.

11. The PD system of claim 1 , which includes a sterilization loop including the fresh PD fluid sides of the first and second volumetric balancing chambers and at least one of (i) at least one reusable solution line or (ii) at least one sealed cover that closes over at least one patient line port and/or drain line port.

12. The PD system of claim 1 , which includes a disinfection loop including the used PD fluid sides of the first and second volumetric balancing chambers and at least one sealed cover that closes over at least one patient line port and/or drain line port.

13. The PD system of claim 1 , which is configured to run a patient drain in which (i) the first and second volumetric balancing chambers are bypassed and the accuracy of PD fluid pump is relied upon or (ii) the first and second volumetric balancing chambers are operated.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 074046/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 074046/0769 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2025
From: JANSSON, OLOF
To: GAMBRO LUNDIA AB
Reel/Frame 071980/0392 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2025
From: GAMBRO LUNDIA AB
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 072399/0969 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
Continuity (2)
Provisional Application 63278290 · Nov 11, 2021
Related Publication 20230146216A1 · May 11, 2023
References Cited (11)
US 4618343A · Polaschegg · 1986 [cited by applicant]
US 5542919A · Simon et al. · 1996 [cited by applicant]
US 20020107474A1 · Noack et al. · 2002 [cited by applicant]
CA 2704411C · 2016 [cited by examiner]
DE 19830928C1 · 1999 [cited by applicant]
EP 3466460A1 · 2019 [cited by applicant]
WO WO2018036859A1 · 2018 [cited by applicant]
WO WO2018202321A1 · 2018 [cited by applicant]
WO WO2022146706A1 · 2022 [cited by applicant]
International Preliminary Report on Patentability from International Patent Application No. PCT/US2022/079376, mailed May 2, 2024. 17 pages. [cited by applicant]
Extended European Search Report dated Jan. 23, 2025, European Patent Application No. EP 24208948.0. [cited by applicant]